Latest Breaking News On - Lifesciences ltd - Page 4 : comparemela.com

Indices: Stock market update: Nifty Pharma index advances 1.43% in a weak market

The Nifty Pharma index was trading 1.43 per cent up at 16410.95.

Zydus Lifesciences inks licensing pact with Daewoong Pharmaceutical

Zydus Worldwide DMCC, a wholly-owned subsidiary, and Daewoong Pharmaceutical Co Ltd have entered into an exclusive licensing agreement to co-develop and commercialise Leuprolide Acetate for depot suspension in six dosage strengths for the US market, Zydus Lifesciences said in a regulatory filing.

Zydus And Daewoong Pharmaceutical Announces Exclusive Licensing Agreement To Co-develop & Commercialize Leuprolide Acetate

Indices: Stock market update: Nifty Pharma index falls 0.1% in a weak market

The Nifty Pharma index was trading 0.1 per cent down at 15482.5.

Eris Lifesciences acquires two businesses from Biocon arm

Eris Lifesciences Ltd, a Mumbai-listed pharmaceutical company backed by private equity firm ChrysCapital and Kuwait Investment Authority, has agreed to purchase Biocon Biologics Ltd’s dermatology and ..